Investing.com - McKesson (NYSE:MCK) reported on Thursday fourth quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
McKesson announced earnings per share of $5.05 on revenue of $59.14B. Analysts polled by Investing.com anticipated EPS of $5.05 on revenue of $61.08B.
McKesson shares are up 6% from the beginning of the year, still down 6.64% from its 52 week high of $198.28 set on March 30. They are under-performing the S&P 500 which is up 11.85% from the start of the year.
McKesson follows other major Healthcare sector earnings this month
McKesson's report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Pfizer had beat expectations on Tuesday with first quarter EPS of $0.93 on revenue of $14.58B, compared to forecast for EPS of $0.7773 on revenue of $13.67B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar